| 14-HDHA | 14-Hydroxy-Docosahexaenoic Acid |
| 17-HDHA | 17-Hydroxy-Docosahexaenoic Acid |
| 17(R)-HDHA | 17(R)-Hydroxy-docosahexaenoic acid |
| 18-HEPE | 18-Hydroxy-Eicosapentaenoic Acid |
| 14-HpDHA | 14-Hydroxyperoxydocosahexaenoic acid |
| 17-HpDHA | 17-Hydroxyperoxydocosahexaenoic acid |
| AA | arachidonic acid |
| ALA | alpha-linoleic acid |
| AT-RvD1 | Aspirin-Triggered Resolvin D1 |
| CD11b | Cluster of Differentiation 11b |
| CD16 | Cluster of Differentiation 16 |
| CD41 | Cluster of Differentiation 41 |
| CD163+ | Cluster of Differentiation 163-positive |
| COX | cyclooxygenase |
| COX-2 | cyclooxygenase-2 |
| CRP | C-Reactive Protein |
| DHA | docosahexaenoic acid |
| EIMD | exercise-induced muscle damage |
| ELISA | enzyme-linked immunosorbent assay |
| EPA | eicosapentaenoic acid |
| ESR | Erythrocyte Sedimentation Rate |
| IGF-1 | Insulin-Like Growth Factor 1 |
| IL-1β | interleukin 1 beta |
| IL-6 | interleukin 6 |
| LA | linoleic acid |
| LC-MS/MS | liquid chromatography–tandem mass spectrometry |
| LOX | lipoxygenase |
| LTs | leukotrienes |
| M1 | macrophage phenotype 1 |
| M2 | macrophage phenotype 2 |
| MaR1 | Maresin 1 |
| NF-κB | nuclear factor kappa beta |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| n-3 PUFAs | omega-3 polyunsaturated fatty acids |
| n-6 PUFAs | omega-6 polyunsaturated fatty acids |
| Pax7+ | paired box 7-positive |
| PGI2/PGI3 | Prostacyclin I2/I3 |
| PGs | prostaglandins |
| PLA2 | Phospholipase A2 |
| PD1 | Protectin D1 |
| ROS | reactive oxygen species |
| RvD1-RvD6 | Resolvins D1 to D6 (DHA-derived) |
| RvE1-RvE3 | Resolvins E1 to E3 (EPA-derived) |
| SPMs | specialized pro-resolving mediators |
| TNF-α | tumor necrosis factor-alpha |
| TXs | thromboxanes |